Nick Pike, chief revenue officer at Vizibl discusses why pharmaceutical companies aren't only interested in the financial benefits when it comes to collaboration.
David Knight, partner and Joshua Marshall, senior associate at Fieldfisher discuss the implications the Covid-19 Technology Access Pool is having on innovation in pharma.
European Pharmaceutical Manufacturer editor Reece Armstrong looks at the issue of diversity in clinical trials and how medicines aren't developed with every patient in mind.
Dr Clive Glover, director, strategy at Pall Corporation, discusses the steps the pharmaceutical industry has taken to speed up the development of a Covid-19 vaccine.
Neal Singh, COO, Icertis, discusses how advancements in artificial intelligence (AI) are helping pharmaceutical manufacturers better manage their supply chains.
Pari Sanghavi, senior director, life sciences supply chain and manufacturing at Cognizant and Jim Lehane, global leader business development at Zenith discuss how manufacturing must change following Covid-19.
